MM-131, a bispecific anti-EpCAM/Met antibody, exhibited both HGF-dependent and -independent inhibition of Met signaling, inhibiting the proliferation of Met-driven HCC, BC, gastric cancer and lung cancer [131]. Here, EPCAM is linked to lung cancer.